{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:34:43Z","timestamp":1791293683222,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T00:00:00Z","timestamp":1199923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T00:00:00Z","timestamp":1199923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1038\/sj.leu.2405082","type":"journal-article","created":{"date-parts":[[2008,1,10]],"date-time":"2008-01-10T11:04:14Z","timestamp":1199963054000},"page":"762-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cooperative genetic defects in TLX3 rearranged pediatric T-ALL"],"prefix":"10.1038","volume":"22","author":[{"given":"P","family":"Van Vlierberghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Homminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zuurbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gladdines-Buijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E R","family":"van Wering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Horstmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H B","family":"Beverloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P P","family":"Meijerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,10]]},"reference":[{"key":"BF2405082_CR1","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.","journal-title":"N Engl J Med"},{"key":"BF2405082_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/sj.leu.2404008","volume":"20","author":"E Clappier","year":"2006","unstructured":"Clappier E, Cuccuini W, Cayuela JM, Vecchione D, Baruchel A, Dombret H et al. Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias. Leukemia 2006; 20: 82\u201386.","journal-title":"Leukemia"},{"key":"BF2405082_CR3","first-page":"1116","volume":"90","author":"K De Keersmaecker","year":"2005","unstructured":"De Keersmaecker K, Marynen P, Cools J . Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia. Haematologica 2005; 90: 1116\u20131127.","journal-title":"Haematologica"},{"key":"BF2405082_CR4","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ng1425","volume":"36","author":"C Graux","year":"2004","unstructured":"Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004; 36: 1084\u20131089.","journal-title":"Nat Genet"},{"key":"BF2405082_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ng2025","volume":"39","author":"I Lahortiga","year":"2007","unstructured":"Lahortiga I, De Keersmaecker K, Van Vlierberghe P, Graux C, Cauwelier B, Lambert F et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 2007; 39: 593\u2013595.","journal-title":"Nat Genet"},{"key":"BF2405082_CR6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","volume":"106","author":"J Soulier","year":"2005","unstructured":"Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005; 106: 274\u2013286.","journal-title":"Blood"},{"key":"BF2405082_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.leu.2403657","volume":"19","author":"F Speleman","year":"2005","unstructured":"Speleman F, Cauwelier B, Dastugue N, Cools J, Verhasselt B, Poppe B et al. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia 2005; 19: 358\u2013366.","journal-title":"Leukemia"},{"key":"BF2405082_CR8","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/blood-2006-04-019927","volume":"108","author":"P Van Vlierberghe","year":"2006","unstructured":"Van Vlierberghe P, van Grotel M, Beverloo HB, Lee C, Helgason T, Buijs-Gladdines J et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 2006; 108: 3520\u20133529.","journal-title":"Blood"},{"key":"BF2405082_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BF2405082_CR10","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1182\/blood-2006-12-064683","volume":"110","author":"E Clappier","year":"2007","unstructured":"Clappier E, Cuccuini W, Kalota A, Crinquette A, Cayuela JM, Dik WA et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 2007; 110: 1251\u20131261.","journal-title":"Blood"},{"key":"BF2405082_CR11","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/sj.leu.2404302","volume":"20","author":"C Graux","year":"2006","unstructured":"Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A . Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 2006; 20: 1496\u20131510.","journal-title":"Leukemia"},{"key":"BF2405082_CR12","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1200\/JCO.2005.05.047","volume":"23","author":"SA Armstrong","year":"2005","unstructured":"Armstrong SA, Look AT . Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 2005; 23: 6306\u20136315.","journal-title":"J Clin Oncol"},{"key":"BF2405082_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrc1880","volume":"6","author":"C Grabher","year":"2006","unstructured":"Grabher C, von Boehmer H, Look AT . Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 2006; 6: 347\u2013359.","journal-title":"Nat Rev Cancer"},{"key":"BF2405082_CR14","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/sj.leu.2402249","volume":"15","author":"OA Bernard","year":"2001","unstructured":"Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffe M, Della Valle V, Monni R et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001; 15: 1495\u20131504.","journal-title":"Leukemia"},{"key":"BF2405082_CR15","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/sj.leu.2402671","volume":"16","author":"TE Hansen-Hagge","year":"2002","unstructured":"Hansen-Hagge TE, Schafer M, Kiyoi H, Morris SW, Whitlock JA, Koch P et al. Disruption of the RanBP17\/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia 2002; 16: 2205\u20132212.","journal-title":"Leukemia"},{"key":"BF2405082_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/gcc.20088","volume":"41","author":"XY Su","year":"2004","unstructured":"Su XY, Busson M, Della Valle V, Ballerini P, Dastugue N, Talmant P et al. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2004; 41: 243\u2013249.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2405082_CR17","first-page":"1212","volume":"91","author":"M van Grotel","year":"2006","unstructured":"van Grotel M, Meijerink JP, Beverloo HB, Langerak AW, Buys-Gladdines JG, Schneider P et al. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica 2006; 91: 1212\u20131221.","journal-title":"Haematologica"},{"key":"BF2405082_CR18","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/sj.leu.2403061","volume":"17","author":"R Berger","year":"2003","unstructured":"Berger R, Dastugue N, Busson M, Van Den Akker J, Perot C, Ballerini P et al. t(5;14)\/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Leukemia 2003; 17: 1851\u20131857.","journal-title":"Leukemia"},{"key":"BF2405082_CR19","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1038\/sj.leu.2402709","volume":"16","author":"L Mauvieux","year":"2002","unstructured":"Mauvieux L, Leymarie V, Helias C, Perrusson N, Falkenrodt A, Lioure B et al. High incidence of Hox11L2 expression in children with T-ALL. Leukemia 2002; 16: 2417\u20132422.","journal-title":"Leukemia"},{"key":"BF2405082_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1182\/blood-2001-11-0093","volume":"100","author":"P Ballerini","year":"2002","unstructured":"Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 2002; 100: 991\u2013997.","journal-title":"Blood"},{"key":"BF2405082_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1182\/blood-2003-05-1495","volume":"103","author":"H Cave","year":"2004","unstructured":"Cave H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004; 103: 442\u2013450.","journal-title":"Blood"},{"key":"BF2405082_CR22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05329","volume":"444","author":"R Redon","year":"2006","unstructured":"Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD et al. Global variation in copy number in the human genome. Nature 2006; 444: 444\u2013454.","journal-title":"Nature"},{"key":"BF2405082_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/01.GIM.0000178503.15559.d3","volume":"7","author":"DJ Waggoner","year":"2005","unstructured":"Waggoner DJ, Raca G, Welch K, Dempsey M, Anderes E, Ostrovnaya I et al. NSD1 analysis for Sotos syndrome: insights and perspectives from the clinical laboratory. Genet Med 2005; 7: 524\u2013533.","journal-title":"Genet Med"},{"key":"BF2405082_CR24","doi-asserted-by":"crossref","unstructured":"van Grotel M, Meijerink JP, van Wering ER, Langerak AW, Beverloo HB, Buijs-Gladdines JG et al. Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia 2007 Oct 11 (advance online publication).","DOI":"10.1182\/blood.V110.11.4220.4220"},{"key":"BF2405082_CR25","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1158\/0008-5472.CAN-06-4381","volume":"67","author":"A Malyukova","year":"2007","unstructured":"Malyukova A, Dohda T, von der Lehr N, Akhondi S, Corcoran M, Heyman M et al. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res 2007; 67: 5611\u20135616.","journal-title":"Cancer Res"},{"key":"BF2405082_CR26","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nature05886","volume":"447","author":"RS Maser","year":"2007","unstructured":"Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007; 447: 966\u2013971.","journal-title":"Nature"},{"key":"BF2405082_CR27","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1084\/jem.20070876","volume":"204","author":"J O\u2019Neil","year":"2007","unstructured":"O\u2019Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204: 1813\u20131824.","journal-title":"J Exp Med"},{"key":"BF2405082_CR28","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1084\/jem.20070872","volume":"204","author":"BJ Thompson","year":"2007","unstructured":"Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007; 204: 1825\u20131835.","journal-title":"J Exp Med"},{"key":"BF2405082_CR29","doi-asserted-by":"crossref","unstructured":"Balgobind B, Van Vlierberghe P, van den Ouweland A, Beverloo HB, Terlouw-Kromosoeto J, van Wering ER et al. Leukemia associated NF1 inactivation in pediatric T-ALL and AML patients lacking evidence for neurofibromatosis. Blood 2007 (in press).","DOI":"10.1182\/blood-2007-06-095075"},{"key":"BF2405082_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/sj.leu.2404624","volume":"21","author":"L Yang","year":"2007","unstructured":"Yang L, Han Y, Suarez Saiz F, Minden MD . A tumor suppressor and oncogene: the WT1 story. Leukemia 2007; 21: 868\u2013876.","journal-title":"Leukemia"},{"key":"BF2405082_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng863","volume":"30","author":"N Kurotaki","year":"2002","unstructured":"Kurotaki N, Imaizumi K, Harada N, Masuno M, Kondoh T, Nagai T et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nature genetics 2002; 30: 365\u2013366.","journal-title":"Nature genetics"},{"key":"BF2405082_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/00043426-200403000-00013","volume":"26","author":"N Al-Mulla","year":"2004","unstructured":"Al-Mulla N, Belgaumi AF, Teebi A . Cancer in Sotos syndrome: report of a patient with acute myelocytic leukemia and review of the literature. J Pediatr Hematol Oncol 2004; 26: 204\u2013208.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BF2405082_CR33","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/ajmg.a.31727","volume":"143","author":"V Martinez-Glez","year":"2007","unstructured":"Martinez-Glez V, Lapunzina P . Sotos syndrome is associated with leukemia\/lymphoma. Am J Med Genet A 20071; 143: 1244\u20131245.","journal-title":"Am J Med Genet A"},{"key":"BF2405082_CR34","first-page":"139","volume":"91","author":"O Ziino","year":"2006","unstructured":"Ziino O, Rondelli R, Micalizzi C, Luciani M, Conter V, Arico M . Acute lymphoblastic leukemia in children with associated genetic conditions other than Down's syndrome. The AIEOP experience. Haematologica 2006; 91: 139\u2013140.","journal-title":"Haematologica"},{"key":"BF2405082_CR35","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1182\/blood.V99.7.2526","volume":"99","author":"J Brown","year":"2002","unstructured":"Brown J, Jawad M, Twigg SR, Saracoglu K, Sauerbrey A, Thomas AE et al. A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay. Blood 2002; 99: 2526\u20132531.","journal-title":"Blood"},{"key":"BF2405082_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1158\/1078-0432.CCR-05-1431","volume":"12","author":"KO Henrich","year":"2006","unstructured":"Henrich KO, Fischer M, Mertens D, Benner A, Wiedemeyer R, Brors B et al. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients. Clin Cancer Res 2006; 12: 131\u2013138.","journal-title":"Clin Cancer Res"},{"key":"BF2405082_CR37","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2006.10.021","volume":"131","author":"MY Kim","year":"2006","unstructured":"Kim MY, Yim SH, Kwon MS, Kim TM, Shin SH, Kang HM et al. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization. Gastroenterology 2006; 131: 1913\u20131924.","journal-title":"Gastroenterology"},{"key":"BF2405082_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1046\/j.1365-2141.2003.04434.x","volume":"122","author":"N Mori","year":"2003","unstructured":"Mori N, Morosetti R, Mizoguchi H, Koeffler HP . Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p. Br J Haematol 2003; 122: 226\u2013230.","journal-title":"Br J Haematol"},{"key":"BF2405082_CR39","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1182\/blood.V92.9.3405","volume":"92","author":"N Mori","year":"1998","unstructured":"Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G et al. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 1998; 92: 3405\u20133409.","journal-title":"Blood"},{"key":"BF2405082_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0145-2126(02)00278-3","volume":"27","author":"B Melendez","year":"2003","unstructured":"Melendez B, Cuadros M, Robledo M, Rivas C, Fernandez-Piqueras J, Martinez-Delgado B et al. Coincidental LOH regions in mouse and humans: evidence for novel tumor suppressor loci at 9q22-q34 in non-Hodgkin's lymphomas. Leuk Res 2003; 27: 627\u2013633.","journal-title":"Leuk Res"},{"key":"BF2405082_CR41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cell.2006.11.052","volume":"128","author":"A Bagchi","year":"2007","unstructured":"Bagchi A, Papazoglu C, Wu Y, Capurso D, Brodt M, Francis D et al. CHD5 is a tumor suppressor at human 1p36. Cell 2007; 128: 459\u2013475.","journal-title":"Cell"},{"key":"BF2405082_CR42","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1093\/nar\/gkm477","volume":"35","author":"A Fischer","year":"2007","unstructured":"Fischer A, Gessler M . Delta-Notch--and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res 2007; 35: 4583\u20134596.","journal-title":"Nucleic Acids Res"},{"key":"BF2405082_CR43","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.274.5289.990","volume":"274","author":"AM Chinnaiyan","year":"1996","unstructured":"Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR et al. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (New York, NY 1996; 274: 990\u2013992.","journal-title":"Science (New York, NY"},{"key":"BF2405082_CR44","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102: 13944\u201313949.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2405082_CR45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0145-2126(94)90098-1","volume":"18","author":"I Plantier","year":"1994","unstructured":"Plantier I, Lai JL, Wattel E, Bauters F, Fenaux P . Inv(16) may be one of the only \u2018favorable\u2019 factors in acute myeloid leukemia: a report on 19 cases with prolonged follow-up. Leuk Res 1994; 18: 885\u2013888.","journal-title":"Leuk Res"},{"key":"BF2405082_CR46","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1600-0609.2007.00854.x","volume":"78","author":"DR Betts","year":"2007","unstructured":"Betts DR, Ammann RA, Hirt A, Hengartner H, Beck-Popovic M, Kuhne T et al. The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG). Eur J Haematol 2007; 78: 468\u2013476.","journal-title":"Eur J Haematol"},{"key":"BF2405082_CR47","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1128\/MCB.16.6.2802","volume":"16","author":"GN Filippova","year":"1996","unstructured":"Filippova GN, Fagerlie S, Klenova EM, Myers C, Dehner Y, Goodwin G et al. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol Cell Biol 1996; 16: 2802\u20132813.","journal-title":"Mol Cell Biol"},{"key":"BF2405082_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0165-4608(90)90165-7","volume":"49","author":"T Inaba","year":"1990","unstructured":"Inaba T, Murakami S, Oku N, Itoh K, Ura Y, Nakanishi S et al. Translocation between chromosomes 8q24 and 14q11 in T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet 1990; 49: 69\u201374.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2405082_CR49","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","volume":"103","author":"T Palomero","year":"2006","unstructured":"Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103: 18261\u201318266.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2405082_CR50","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1101\/gad.1450406","volume":"20","author":"AP Weng","year":"2006","unstructured":"Weng AP, Millholland JM, Yashiro-Ohtani Y, Arcangeli ML, Lau A, Wai C et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma. Genes Dev 2006; 20: 2096\u20132109.","journal-title":"Genes Dev"},{"key":"BF2405082_CR51","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758\u2013764.","journal-title":"Nature"},{"key":"BF2405082_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2","volume":"9","author":"M Little","year":"1997","unstructured":"Little M, Wells C . A clinical overview of WT1 gene mutations. Hum Mutat 1997; 9: 209\u2013225.","journal-title":"Hum Mutat"},{"key":"BF2405082_CR53","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1182\/blood.V91.8.2961.2961_2961_2968","volume":"91","author":"L King-Underwood","year":"1998","unstructured":"King-Underwood L, Pritchard-Jones K . Wilms\u2019 tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. Blood 1998; 91: 2961\u20132968.","journal-title":"Blood"},{"key":"BF2405082_CR54","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V87.6.2171.bloodjournal8762171","volume":"87","author":"L King-Underwood","year":"1996","unstructured":"King-Underwood L, Renshaw J, Pritchard-Jones K . Mutations in the Wilms' tumor gene WT1 in leukemias. Blood 1996; 87: 2171\u20132179.","journal-title":"Blood"},{"key":"BF2405082_CR55","first-page":"405","volume":"6","author":"H Miwa","year":"1992","unstructured":"Miwa H, Beran M, Saunders GF . Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 1992; 6: 405\u2013409.","journal-title":"Leukemia"},{"key":"BF2405082_CR56","first-page":"970","volume":"7","author":"T Miyagi","year":"1993","unstructured":"Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I . Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells. Leukemia 1993; 7: 970\u2013977.","journal-title":"Leukemia"},{"key":"BF2405082_CR57","first-page":"926","volume":"89","author":"E Barragan","year":"2004","unstructured":"Barragan E, Cervera J, Bolufer P, Ballester S, Martin G, Fernandez P et al. Prognostic implications of Wilms\u2019 tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica 2004; 89: 926\u2013933.","journal-title":"Haematologica"},{"key":"BF2405082_CR58","first-page":"270","volume":"91","author":"L Chiusa","year":"2006","unstructured":"Chiusa L, Francia di Celle P, Campisi P, Ceretto C, Marmont F, Pich A . Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia. Haematologica 2006; 91: 270\u2013271.","journal-title":"Haematologica"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2405082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405082","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2405082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:20:47Z","timestamp":1648779647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2405082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,10]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["BF2405082"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2405082","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,10]]},"assertion":[{"value":"29 October 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}